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 The original requirement for a competency framework for 
prescribers was to identify the essential skills for non-
medical prescribers. However, core prescribing competencies 
are relevant to any prescriber. The new, revised version is 
especially relevant for doctors/physicians. Doctors are the 
most frequent prescribers – prescribing is the most common 
therapeutic intervention. The quantity and complexity 
of medicine use is increasing through multiple treatment 
strategies/pathways for multiple comorbidities, resulting in 
polypharmacy – especially with long-term conditions. This 
is against a background of the ongoing introduction of new 
drugs with novel mechanisms of action with increased risks 
of adverse effects, compounded by drug-drug and disease-
drug interactions. This has increased the need for monitoring 
and follow-up, including identiﬁcation and management of 
poor adherence. It is challenging for doctors to maintain 
safe and effective prescribing and train other doctors and 
non-medical prescribers within the multidisciplinary team.  
 The prescribing competency framework provides a 
systematic approach to support doctors to prescribe safely 
and effectively. It can be used by medical schools to teach 
prescribing, including preparation for the prescribing safety 
assessment; by F1/F2 doctors to support prescribing in early 
years; as part of prescribing quality improvement initiatives 
and as a continuing professional development framework in 
general practice or acute care settings. 
 The need for a prescribing competency framework 
 Increasing complexity of prescribing 
 Medicines are used more than any other intervention to 
manage medical conditions. Both the number of medicines 
prescribed and the complexity of the medicine regimens 
that patients take are increasing. As the population ages and 
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 The need for a prescribing competency framework to 
address the burden of complex polypharmacy among 
multiple long-term conditions 
multiple comorbidities become more prevalent, polypharmacy is 
increasingly becoming the norm for patients. 1 A Royal College of 
General Practitioners (RCGP) review of the workload in general 
practice highlighted the 19% increase in GP consultations 
in England between 2008–09 and 2013–14 and the increased 
complexity of those patients presenting, citing the number of 
patients with comorbidities are set to rise by 53% between 2008 
and 2018. 2 A review of GP workload in Northern Ireland last 
year demonstrated that, in 2013, 39 million prescription items 
were prescribed – approximately 20 items per patient per year. 3 
 This increase in complexity means that besides developing 
and maintaining prescribing competency for individual 
conditions, prescribers have the challenge of keeping up to date 
with new medicines as they come on the market and being 
aware of the potential for interaction between medicines in 
patients with multiple comorbidities. 1 
 Key points 
 Prescribing safely and effectively is a challenge, particularly 
when prescribing for people with multiple long-term conditions 
and complex polypharmacy. 
 Doctors will continue to be challenged as new medicines are 
introduced with novel mechanisms of action, adverse effects 
and drug-drug or disease-drug interactions. 
 The need to understand how patients use medicines in practice 
is increasingly being recognised and requires more monitoring 
and follow-up, including a focus on adherence.   
 A core set of prescribing competencies relevant to all 
prescribers has been updated and can be used to underpin safe 
and effective prescribing. 
 The competency framework can be used by medical schools to 
support doctors in training and by all doctors at any stage in 
their career, as well as helping doctors supporting non-medical 
prescribers. 
 KEYWORDS: Competency framework, prescriber, prescribing 
and competency ■ 
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 Specialists in hospitals are now often faced with patients 
taking medicines for two or three long-term conditions in 
addition to the one that they are treating. This shift is reflected 
in the debate about the increasing need for generalist medical 
skills in hospitals so that there are doctors able to coordinate 
the care of patients with complex needs. 4 In fact, the trend 
towards increased specialisation within medical training has 
recently come under scrutiny, not least in the  Shape of training 
review. 5 This report makes the case for more generalist training 
for all doctors to meet patient needs. 
 Similarly, in general practice, it has been recognised that GPs 
need to enhance their expert generalist clinical skills but also need 
to develop additional skills for extended roles. 6 The need to ensure 
that patients' medicines are regularly reviewed, particularly 
those with multiple comorbidities, has driven the debate about 
consultation times and the effective use of the multidisciplinary 
team skill mix (including other prescribing professions such as 
nurses and pharmacists) to ensure that this happens. 7 
 Clear need to optimise the use of medicines in practice 
 Effective use of medicines is often focused on getting the choice 
of medicine right for an individual patient. While this has 
the potential to improve quality of life and patient outcomes, 
how the medicines are used in practice is equally important. 
However, there are a range of problems with this 8 (Box  1 ). 9–15 
 Optimising the way that medicines are used is a priority 
not just for the UK but for many developed healthcare 
systems. This level of priority is reflected by the fact that the 
National Institute for Health and Care Excellence (NICE) has 
developed a guideline on medicines optimisation, which makes 
recommendations for how doctors, pharmacists and other 
members of the multiprofessional team can improve the way 
medicines are used. 16 
 Poor adherence (whether intentional or unintentional) is an 
example of where medicines use can go wrong in practice. Poor 
adherence has been shown to be alarmingly prevalent in patients 
starting a new medicine with one study reporting that 10 days 
after first starting a medicine, almost a third of patients are 
already non-adherent. Moreover, while 45% of these patients are 
intentionally non-adherent, 55% don't actually realise that they 
are not taking their medicines correctly. 9 Similarly, a quarter of 
patients attending a specialist hypertension centre in Leicester for 
suboptimal blood pressure control apparently due to ‘resistant’ 
hypertension were totally or partially non-adherent to their 
antihypertensive treatment (approximately 10% with total and 
15% with partial non-adherence). This audit was a ‘game-changer’ 
in the approach to resistant hypertension: awareness of such high 
prevalence of non-adherence can help identify the problem in a 
given patient and avoid unnecessary treatment escalation. 17 
 The potential risks to patient safety were set out by the 
Institute of Medicine in 1999. 18 In 2002, Wilson and Sheikh 
considered public safety in primary care and identified 
prescribing as one of four key safety issues. 19 They proposed 
that ‘3–5% of all prescriptions in primary care might cause 
problems and one third of these can be classified as serious'. 
In the PRACtICe (prevalence and causes of prescribing errors 
in general practice) study, which looked at errors in general 
practice, a wide range of underlying causes of error were 
identified relating to the prescriber, the patient, the team, the 
working environment, the task, the computer system and the 
primary/secondary care interface. 13 As prescribing is recognised 
as an area of potential risk to patients, the report recommended 
a review of the RCGP's curriculum. 13 
 Prescribing errors may be more prevalent in the hospital 
setting than primary care. The EQUIP study found a mean 
error rate of 8.9 errors per 100 medication orders in hospital and 
identified targets for intervention to reduce prescribing errors; 
these included undergraduate medical education programmes, 
foundation year 1 education, and multiprofessional education, 
as well as clinical working environments. 12 
 While ‘high-risk’ medications, such as warfarin and disease 
modifying anti-rheumatic drugs (DMARDs), present a 
particular threat to patient safety, this risk is often preventable. 
This was highlighted in a systematic review whereby the 
incidence of preventable medicines-related admissions to hospital 
was 3.7% (median; range 1.4–15.4%). 20 Importantly, 50% of all 
such preventable drug-related admissions were linked to just four 
groups of medicines: antiplatelets, diuretics, nonsteroidal anti-
inflammatory drugs (NSAIDs) and anticoagulants. 
 Changing patient pathways and care models 
 It is not only the medicines prescribed that are increasing in 
number and complexity, the pathways that patients follow are 
 Box 1.  Are we making the most of medicines? 
 Do patients take their medicines? 
 >  Only 16% of patients who are prescribed a new medicine 
take it as prescribed, experience no problems and receive as 
much information as they need. 9 
 >  Ten days after starting a medicine, almost a third of patients 
are already non-adherent – of these, 55% don't realise 
they are not taking their medicines correctly, while 45% are 
intentionally non-adherent. 9 
 How well do we use medicines? 
 >  A study conducted in care homes found that over two thirds of 
residents were exposed to one or more medication errors. 10 
 >  Over half a million medication incidents were reported to the 
National Patient Safety Agency between 2005 and 2010; 
16% of them involved actual patient harm. 11 
 >  In hospitals, the General Medical Council's EQUIP study 
demonstrates a prescribing error rate of almost 9%. 12 
 >  In general practice, an estimated 1.7 million serious 
prescribing errors occurred in 2010. 13 
 Is the NHS getting the best value from medicines? 
 >  In primary care, around £300 million of medicines are 
wasted per year (this is likely to be a conservative estimate), 
of which £150 million is avoidable. 14 
 >  At least 6% of emergency re-admissions are caused by 
avoidable adverse reactions to medicines. 15 
 Are patients getting the right medicines? 
 >  Analysis of the NHS Atlas of Variation highlights unwarranted 
variations in the prescribing of some medicines across 
England. 
Taken from  Medicines optimisation: helping patients make the most of their 
medicines . 8 
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also evolving. In England, the  Five Year Forward View 21 proposed 
the development of radically different models of delivering care 
that are now being realised through its Vanguard programme. 
There are currently 50 vanguard sites, each taking the lead on 
the development of new care models that will act as a blueprint 
for the NHS. 22 The Vanguards are active across all sectors of 
care and are looking at new approaches to the coordination of 
urgent and emergency care, enhanced health in care homes, 
moving specialist care out of hospitals into the community, 
joining up GP, hospital, community and mental health services, 
and acute care collaborations. We are already starting to see the 
lines between hospital and primary care blurring, with patients 
previously managed in a hospital setting either transferred for 
ongoing care to community or primary care, or treated there 
in the first instance. We have also seen hospitals outsourcing 
ongoing medicines supplies and, in some cases, ongoing care to 
homecare companies; this ranges from low tech through to high 
tech and complex medicines regimens. 23 
 What this means for prescribers is that the patient's care and, 
with it, the prescribing of medicines will move through a range of 
different – and in some cases new – settings. This is already having 
an impact on the systems and governance around prescribing and, 
therefore, the competencies that are associated with managing the 
systems aspects of prescribing should not be underestimated. 
 More professions prescribing 
 This shift to new models of care delivery is in some respects 
being supported by the changes to legislation made in the last 
15 years to enable professions other than doctors and dentists 
to prescribe. This has allowed the health service to make use 
of the skills of these professionals to support the delivery of 
services. While the numbers of these prescribers are small 
relative to doctors, they are increasing throughout the health 
service across a wide range of roles, which means that doctors 
may increasingly be working alongside other professionals able 
to prescribe in their own right. 
 After successful completion of an approved education 
programme, nurses, pharmacists, optometrists, 
physiotherapists, podiatrists and therapeutic radiographers can 
prescribe independently within their own areas of competence; 
there are few restrictions on the medicines that they can 
prescribe. Regulatory standards underpin prescribing by these 
professional groups and, once qualified, prescribers must record 
their qualification with their professional regulator and have a 
responsibility to remain up to date with the knowledge and skills 
that enable them to prescribe competently and safely. As well as 
prescribing independently, these professionals (plus dieticians 
and diagnostic radiographers) can enter into a supplementary 
prescribing agreement with a doctor for an individual patient. 
This requires the development of a clinical management plan 
that sets the scope of what the supplementary prescriber can 
prescribe and when referral back to the doctor is necessary. 
 How a competency framework can help 
 The prescribing competencies that doctors should expect to 
develop and maintain extend beyond the identification of an 
appropriate medicine for an individual patient. Prescribing is 
multifaceted and as much about managing systems risk and 
the way patients use their medicines in practice as it is about 
clinical pharmacology – as identified by the analysis of causes 
of errors in general practice in the PRACtice study. 13 
 A generic prescribing competency framework can support 
doctors to develop and maintain a holistic set of competencies 
that are patient-centred and frame prescribing in the wider 
context. By providing a single competency framework, there is the 
opportunity to bring doctors and other prescribing professionals 
together and to harmonise education for prescribers. 
 How doctors use the framework 
 Teaching prescribing to undergraduates 
 Experience from the other professions has shown that the 
framework is a practical and effective way to underpin the 
teaching of prescribing. The framework has been used widely 
by higher education institutes to provide a basis for developing 
teaching programmes and as a portfolio to demonstrate 
attainment of competencies (Box  2 ). 
 The framework can be mapped to existing teaching in medical 
schools to ensure that all relevant areas of prescribing are 
 Box 2.  Using the competency framework to train 
prescribers 
 The Centre for Professional Development and Lifelong Learning at 
Keele University has been offering courses for trainee pharmacist 
prescribers since 2003. Throughout the last 13 years, the 
competency frameworks relating to prescribing have been used 
both to underpin the education of the trainee prescribers and for 
assessment purposes. 
 Key to delivery of the independent prescribing course has been the 
development of a ‘learning in practice/prescribing competency 
workbook’. The workbook is structured so that the course learning 
outcomes and prescribing competencies are linked. This workbook 
requires the student to document, through three separate review 
meetings with their designated medical practitioner (DMP), how 
they are working towards (in the initial and intermediate meetings) 
gaining competence in their specialist area of prescribing. At the 
final review meeting, the student needs to demonstrate that they 
are competent to prescribe by providing evidence for all of the 
course learning outcomes and prescribing competencies. 
 The students at Keele University use a structured reflective portfolio 
to collect evidence of their competence of the behavioural indicators 
that underpin the overarching prescribing competences. They are 
encouraged to write regularly in their portfolio, reflecting on the 
learning they have gained during their period of study. This could 
include learning from study days, directed reading, observation of 
other prescribers, direct patient care observed by others, assessment 
– such as case presentations and Objective Structured Clinical 
Examinations (OSCE) – or any other source that provides evidence 
of meeting the prescribing competency standards. By the end of 
the study period, the student is required to map all of their evidence 
within the portfolio against the 16 course learning outcomes and 
nine prescribing competencies. This is submitted to the university 
and assessed by tutors who are also prescribers. 
 Students must demonstrate their competence to prescribe by 
meeting all of the competencies described in the framework 
before they are allowed to register as prescribers. 
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governance processes , such as reaccreditation or revalidation, 
to ensure that prescribers remain competent to prescribe over 
time. In general practice, it has been used for critical case 
analysis and can support a multidisciplinary or team approach 
to continuing professional development in prescribing. It has 
also been used to support return to prescribing practice after a 
period of absence. 
 The General Medical Council and the Academy of Medical 
Royal Colleges have recently completed a consultation on 
generic professional capabilities for all doctors. 27 The ethos of 
this proposal is that such capabilities should be integrated ‘into 
all aspects of medical education and practice’. The inclusion 
of specific content on prescribing medicines safely highlights 
that safe prescribing is recognised as a core generic professional 
capability for doctors, reflecting the content of the prescribing 
competency framework. 
 The generic professional capabilities consultation also 
included many aspects referred to in the prescribing 
competency framework, such as communication, leadership 
and teamwork, patient safety and quality improvement, 
and dealing with complexity and uncertainty. The fact that 
two educational frameworks coalesce in such a way, having 
consulted widely and independently on each, endorses the 
direction of travel for both. 
 The structure of the competency framework 
 The competency framework consists of ten competencies. 28 
Each competency is supported by a list of indicators that 
describe how prescribers with that competency will be working. 
A key feature of this framework is that it is generic, so each 
prescriber will need to contextualise the statement for their 
individual prescribing practice. This might be for a specific 
patient group, eg children, or a specific category of medicines, 
eg for chemotherapy. The emphasis of the framework is in the 
development of skills rather than as a checklist exercise. 
 The prescribing framework reflects the multifaceted nature 
of prescribing. The ten competencies (Fig  1 ) are split into two 
areas: the consultation and prescribing governance. Each of 
the competencies is supported by statements that describe 
the activity or outcomes that prescribers should be able to 
demonstrate. 
 Conclusion 
 There is an increasing challenge to doctors when prescribing, 
particularly for patients with multiple long-term conditions. 
There is a tension between the delivery of holistic and patient-
centred care and the application of evidence-based medicine. 
The trend towards increased specialisation within medical 
training is now being questioned and the case for more 
generalist training for all doctors to meet patient needs is 
increasingly being made. 
 The prescribing competency framework recognises this 
tension by presenting the framework in two sections – the 
consultation section, with a focus on the individual patient, and 
the prescribing governance section. 
 While doctors prescribe as a frequent patient intervention, the 
extension of prescribing skills to other healthcare professionals 
means this skill is no longer the prevail of one professional group. 
There is the potential for interprofessional learning and the 
covered. It is consistent with the British Pharmaceutical Society 
curriculum in clinical pharmacology and prescribing for 
medical students. 24 It offers medical schools that are co-located 
with higher education institutions providing postgraduate 
training in prescribing for other professions a framework to 
develop multidisciplinary education sessions with them. Taking 
this multiprofessional approach will help doctors and, in 
particular, junior doctors to understand that other professional 
groups have prescribing competencies. 
 Using the framework in this way will support the 
recommendations of the EQUIP study, which highlighted the 
importance of undergraduate education and multidisciplinary 
education as ways to reduce prescribing errors. 12 
 Supporting foundation doctors 
 The Prescribing Safety Assessment 25 maps across to the 
competency framework and provides a basis for supporting 
doctors in their early years of practice . It may be particularly 
useful, along with structured support sessions, for those doctors 
who need additional support with prescribing at the beginning 
of their career, including doctors who may have registered 
outside of the UK. 
 Supporting quality improvement 
 The Scottish Patient Safety Programme in Primary care 
(SPSP-PC) has recognised the risk that prescribing errors 
pose to patient safety and has put together a number of 
resources, including medicines management across the primary 
secondary care interface. 26 A focus on high-risk medicines, as 
demonstrated by the SPSP-PC initiative, has the potential to 
significantly reduce patient harm. It follows that the prescribing 
competency framework is therefore a useful tool for doctors to 
apply in quality improvement for prescribing. 
 It could be argued that focusing attention on improvement 
in prescribing practice in primary care would reap significant 
benefits. The prescribing competency framework provides 
a touchstone for primary care practitioners to review their 
prescribing practices and inform their continuing professional 
development. There is a real opportunity for GP training 
programmes to actively endorse the prescribing competency 
framework to ensure that GP trainees entering the GP 
workforce are fully aware of the risks when prescribing in 
primary care and understand the potential impact of human 
factors and complex prescribing systems. 
 Continuing professional development 
 Perhaps the most significant strength of the competency 
framework is that it provides a tool around which to structure 
ongoing continuing professional development in prescribing 
that stays with doctors as their practice develops. This 
is because it is a generic framework that focuses on core 
competencies and can be used over time as doctors develop 
their generalist skills and/or specialise. It is the generic nature 
of the framework and the need to apply it to a prescribers scope 
of practice that make it suitable for use by anyone prescribing, 
regardless of their professional background. 
 The framework has already been used extensively across the 
NHS by professional groups (other than doctors) as part of 
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embedding of generic professional skills for all. The prescribing 
competency framework facilitates this, highlighting the 
importance to all healthcare providers of working within a team 
and a giving cognisance to the importance of wider systems. 
 Continued engagement between the Royal Pharmaceutical 
Society, the Academy of Medical Royal Colleges, the 
Royal College of Physicians, the Royal College of General 
Practitioners, the General Medical Council and Medical 
Schools Council to explore how the prescribing framework 
might be embedded in practice would be welcome. ■ 
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 Fig 1.  The prescribing compe-
tency framework . The full compe-
tency framework can be found on 
the Royal Pharmaceutical Society 
website ( www.rpharms.com/pre-
scribingframework ). Reproduced 
with permission from the Royal 
Pharmaceutical society. 
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